Login
Toggle navigation
Videos
Categories
Trending
Watch NRG Energy CEO Mauricio Gutierrez discuss #EmbracingSustainability at NRG and challenge Steve Mollenkopf to share their sustainability efforts.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Mauricio Gutierrez, CEO of NRG Energy
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:00:00
Manjinder Kandola, M.D.
00:10:00
Golden Arrow Resources: Advancing the San Pietro Copper-Gold-Cobalt Project in Chile
00:10:00
Jeffrey Gundlach Analyzes Fed Policy, Inflation, and Market Outlook | Jeffrey Gundlach, CEO , DoubleLine Capital.
00:10:00
Valens Semiconductor CEO Gideon Ben-Zvi discusses moving data through cables and related innovations.
00:10:00
Alex Griffin on Transitioning from Banking to Independent Advising: A Journey of Intentional Change
00:10:00
Philippine Economy: Challenges and Opportunities| president , Ayala Corporation
00:10:00
Discovering Opportunities in China: Insights from PAG's Weijian Shan | Weijian Shan, CEO, PAG.
00:00:00
Resident physician / Horatio Thomas, M.D.
00:10:00
Aims to democratize access to entrepreneurship by bridging the gap between untapped founders|Austin Clements,Managing Partner,Slauson & Co
00:10:00
Private Equity Trends and Market Dynamics: Insights from Dave Layton | Dave Layton, CEO, Partners Group.
00:10:00
CEO of Logan Energy, Discusses the Potential of SEA Fuel in Advancing Sustainable Energy Solutions | Bill Ireland, CEO, Logan Energy Corp.
00:10:00
Mike Gold on Intermedia's Strategic Growth and Market Evolution | Michael Gold, CEO, Intermedia Partners.